121 related articles for article (PubMed ID: 29087218)
1. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate.
Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V; Babu PP
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1809-1829. PubMed ID: 29087218
[TBL] [Abstract][Full Text] [Related]
2. Galactose-Anchored Gelatin Nanoparticles for Primaquine Delivery and Improved Pharmacokinetics: A Biodegradable and Safe Approach for Effective Antiplasmodial Activity against P. falciparum 3D7 and in Vivo Hepatocyte Targeting.
Kumar H; Gothwal A; Khan I; Nakhate KT; Alexander A; Ajazuddin ; Singh V; Gupta U
Mol Pharm; 2017 Oct; 14(10):3356-3369. PubMed ID: 28836792
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles.
Omwoyo WN; Ogutu B; Oloo F; Swai H; Kalombo L; Melariri P; Mahanga GM; Gathirwa JW
Int J Nanomedicine; 2014; 9():3865-74. PubMed ID: 25143734
[TBL] [Abstract][Full Text] [Related]
4. Optimisation of chloroquine phosphate loaded nanostructured lipid carriers using Box-Behnken design and its antimalarial efficacy.
Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V
J Drug Target; 2018 Aug; 26(7):576-591. PubMed ID: 29057679
[TBL] [Abstract][Full Text] [Related]
5. Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.
Levatić J; Pavić K; Perković I; Uzelac L; Ester K; Kralj M; Kaiser M; Rottmann M; Supek F; Zorc B
Eur J Med Chem; 2018 Feb; 146():651-667. PubMed ID: 29407988
[TBL] [Abstract][Full Text] [Related]
6. Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs.
Movellan J; Urbán P; Moles E; de la Fuente JM; Sierra T; Serrano JL; Fernàndez-Busquets X
Biomaterials; 2014 Sep; 35(27):7940-50. PubMed ID: 24930847
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and cellular localization of a fluorescent probe of the antimalarial 8-aminoquinoline primaquine.
McQueen A; Blake LD; Azhari A; Kemp MT; McGaha TW; Namelikonda N; Larsen RW; Manetsch R; Kyle DE
Bioorg Med Chem Lett; 2017 Oct; 27(20):4597-4600. PubMed ID: 28939120
[TBL] [Abstract][Full Text] [Related]
8. Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis.
Wu KW; Sweeney C; Dudhipala N; Lakhani P; Chaurasiya ND; Tekwani BL; Majumdar S
AAPS PharmSciTech; 2021 Sep; 22(7):240. PubMed ID: 34590195
[TBL] [Abstract][Full Text] [Related]
9. Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents.
Beus M; Fontinha D; Held J; Rajić Z; Uzelac L; Kralj M; Prudêncio M; Zorc B
Molecules; 2019 Aug; 24(15):. PubMed ID: 31374989
[TBL] [Abstract][Full Text] [Related]
10. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
11. Toxicological study of the primaquine phosphate loaded chitosan nanoparticles in mice.
Rajera R; Nagpal K; Singh SK; Mishra DN
Int J Biol Macromol; 2013 Nov; 62():18-24. PubMed ID: 23973494
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Vásquez AM; Sanín F; Alvarez LG; Tobón A; Ríos A; Blair S
Biomedica; 2009 Jun; 29(2):307-19. PubMed ID: 20128355
[TBL] [Abstract][Full Text] [Related]
13. Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes.
Miatmoko A; Nurjannah I; Nehru NF; Rosita N; Hendradi E; Sari R; Ekowati J
Sci Rep; 2021 Jun; 11(1):12420. PubMed ID: 34127730
[TBL] [Abstract][Full Text] [Related]
14. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
15. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
[TBL] [Abstract][Full Text] [Related]
16. 5-Phenoxy Primaquine Analogs and the Tetraoxane Hybrid as Antimalarial Agents.
Jansongsaeng S; Srimongkolpithak N; Pengon J; Kamchonwongpaisan S; Khotavivattana T
Molecules; 2021 Jun; 26(13):. PubMed ID: 34208832
[TBL] [Abstract][Full Text] [Related]
17. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
18. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
19. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria.
Ali Z; Mishra N; Baldi A
Artif Cells Nanomed Biotechnol; 2016; 44(2):545-9. PubMed ID: 25340261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
